AMP, along with the daily practice of SKY, during normal life (pre-COVID-19 phase) reduced mRNA expression of IL1β, IL6, and TNF and increased mRNA expression of SOD, catalase, and GPx. This evidence concerns the gene IL1B and COVID-19.